Calprotectin can play an inflammatory role in acne vulgaris
dc.authorwosid | Korkmaz, Selma/W-4142-2017 | |
dc.authorwosid | Korkmaz, Selma/JRX-3713-2023 | |
dc.contributor.author | Korkmaz, Selma | |
dc.contributor.author | Ficicloglu, Sezin Kuru | |
dc.date.accessioned | 2024-06-12T10:50:28Z | |
dc.date.available | 2024-06-12T10:50:28Z | |
dc.date.issued | 2018 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Introduction: Acne vulgaris (AV) is a chronic inflammatory disorder of the pilosebaceous unit. Although various mechanisms have been indicated in the etiopathogenesis of acne vulgaris, the exact pathophysiology is still unknown. Aim: To investigate the level of calprotectin in acne vulgaris and its levels relationship with disease severity. Material and methods: A total of 66 AV patients, who were divided into 33 mild and 33 moderate-severe cases, and 30 healthy controls were enrolled in the study. Disease severity was assessed using the Global Acne Score. According to this scale, patients whose Global Acne Score was 1-18 had mild acne, those with a score of 19-30 had moderate acne, those with a score of 31-38 had severe acne, and those with a score greater than 39 had very severe acne. Serum calprotectin levels of all participants were measured by enzyme-linked immunosorbent assay method. Results: The serum calprotectin levels in the moderate-severe AV group were significantly higher than that of the mild AV group (p < 0.001). In addition, the scrum calprotectin level in the mild AV group was significantly higher than that of the healthy control group (p = 0.047). However, in the Spearman's correlation analysis, the scrum calprotectin level and GAS were not correlated in AV patients (p = 0.171, r = 0.179). Conclusions: Serum calprotectin levels are increased in mild and moderate AV patients. | en_US |
dc.identifier.doi | 10.5114/ada.2017.71286 | |
dc.identifier.endpage | 399 | en_US |
dc.identifier.issn | 1642-395X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 30206454 | en_US |
dc.identifier.scopus | 2-s2.0-85052111728 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 397 | en_US |
dc.identifier.uri | https://doi.org/10.5114/ada.2017.71286 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/17995 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000442539600012 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Termedia Publishing House Ltd | en_US |
dc.relation.ispartof | Postepy Dermatologii I Alergologii | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Acne Vulgaris | en_US |
dc.subject | Calprotectin | en_US |
dc.subject | Inflammation | en_US |
dc.subject | S100a9 | en_US |
dc.title | Calprotectin can play an inflammatory role in acne vulgaris | en_US |
dc.type | Article | en_US |